|

For Immediate Release:
Company Contact Investor
Contact
Media
Contact
321-235-3150 John
Nesbett / Karen Pisciotta
Tony Herrling
inquiry@rotech.com Lippert/Heilshorn
& Associates Burson-Marsteller
321-235-3150
321-235-3151
investor@rotech.com
media@rotech.com
Rotech Emerges From Chapter 11
Through Spin-off from Parent Company
Leading Respiratory Care Provider Secures $275 Million Credit Facilities;
Issues $300 Million Senior Subordinated Notes
ORLANDO, Fla. - March 27, 2002 - Rotech Healthcare Inc., a leading provider
of
home respiratory therapy and durable medical equipment and services, announced
today
that its predecessor, Rotech Medical Corporation, has spun-off from its parent
company
and emerged from Chapter 11, and that the new company will operate as an independent,
standalone entity. Rotech made the unique spin-off possible by securing $575 million
in
exit financing.
Rotech Medical was a subsidiary of Integrated Health Services (IHS), a provider
of post-acute care and related specialty healthcare. When IHS filed for bankruptcy
in February 2000, Rotech, as a guarantor of IHS bank debt, voluntarily filed
for Chapter 11. As part of Rotechs plan of reorganization, which was confirmed
on February 13, 2002 by the US Bankruptcy Court and which became effective on
March 26, 2002, Rotech is no longer an IHS subsidiary.
We are pleased to move beyond the constraints of Chapter
11 and continue serving our clients, setting standards of excellence for home
health care, and growing our business, said Stephen Linehan, President and
Chief Executive Officer of Rotech Healthcare Inc. We are confident that
our new corporate and financial structure will provide a solid platform to advance
our competitive position in the marketplace.
In connection with the Companys emergence from Chapter
11, a syndicate of financial institutions, led by UBS Warburg LLC and Goldman
Sachs Credit Partners, L.P., have extended to Rotech Healthcare $275 million in
senior secured credit facilities. The facilities include a $200 million, six-year
term loan facility and a $75 million, five-year revolving credit facility. The
facilities are guaranteed by substantially all the assets of Rotech Healthcare.
Rotech also announced that it has issued $300 million of 9½%
Senior Subordinated Notes, due 2012. Rotech may redeem up to 35% of the notes
with the net proceeds of qualified equity offerings, prior to April 1, 2005. The
Company may redeem the notes, in whole or in part, at any time on or after April
1, 2007.
All of the net proceeds from the credit facilities and the
Senior Subordinated Notes will be distributed to Rotech Medical’s creditors under
the Company’s plan of reorganization. The revolving credit facility will be used
for general corporate purposes, including working capital, acquisitions, and capital
expenditures.
The Senior Subordinated Notes have not been registered under
the Securities Act or under any state securities laws and unless so registered,
may not be offered or sold in the United States, except pursuant to an exemption
from the registration requirements of the Securities Act and applicable state
securities laws.
About Rotech Healthcare
Rotech Healthcare Inc. is a leading provider of home respiratory care and durable
medical equipment and services to patients with breathing disorders such as chronic
obstructive pulmonary diseases (COPD). The Company provides its equipment and
services in 47 states through over 600 operating centers, located principally
in non-urban markets. Rotech’s local operating centers ensure that patients receive
individualized care, while its nationwide coverage allows the Company to benefit
from significant operating efficiencies.
Forward-looking Statements
Statements contained in this press release may contain forward-looking statements
as contemplated by the 1995 Private Securities Litigation Reform Act that are
based on management’s current expectations, estimates and projections. Words such
as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” variations
of such words and similar expressions are intended to identify such forward-looking
statements. Forward-looking statements are subject to known, and unknown risks
and uncertainties, which could cause actual results to differ materially from
those projected or implied in the forward-looking statements. Rotech Healthcare
Inc. does not undertake any obligation to publicly release any revisions to any
forward-looking statements to reflect events or circumstances after the date of
this release or to reflect the occurrence of unanticipated events.
|